Latest posts tagged with #CARTcell on Bluesky
Our ExPeCT CD-19 (obe-cel) is a precision CAR T-cell monitoring assay that transforms post-infusion uncertainty into actionable clinical insight.
🔎SEE THE DATA 👉 www.eurofins-viracor.com/test-menu/33...
#obecel #cartcell #autolus
Leveraging #ComputationalBiology at scale to individualize #Immunotherapy: www.nature.com/articles/s41... @JoeFraietta @carlhjune #CARTcelltherapy #CellTherapy #CARTCell #TranslationalScience
#MedNews - The CAR T-cell therapy lisocabtagene maraleucel elicits high rates of durable responses in people with relapsed or refractory marginal zone #lymphoma, a population with a high unmet need.
Full story 👉 buff.ly/N2s5kHT
#OncSky #CARTcell
Missed our sold-out event in Paris? We’re bringing the global experts to you!
www.isctglobal.org/workforce-de...
ISCT’s new on-demand virtual course - The Use of Cell Therapies for Autoimmune Diseases: CAR-T - is officially live.
#CARTcell #CellTherapy #AutoimmuneDisease #ISCT #CGTtranslation
The authors of this Blood Cancer Discovery study conducted a comparative analysis of the long-term efficacy and safety of two single-arm trials for relapsed/refractory diffuse large B-cell #lymphoma.
👉Read more: Long-term Outcomes of CAR T ± ASCT in R/R DLBCL buff.ly/m8e6taD #lymsm #cartcell
"Patients do not have to remain at the CAR_T site if they're doing well."
Catch the latest SOHO Insider Brown Bag Series as Loretta Nastoupil and Dr.Tara Graff explore new pathways for returning CAR-T patients to community care sooner. #CommunityOncology #CARTcell
sohoinsider.com/cellular-the...
⏳ Final countdown: Join the EBMT-EHA 8th European CAR T-cell Meeting this week in person or virtually. 🌎🧑💻
Register now and join the visionaries shaping the future of cell therapy 👉 ebmt.org/events/ebmt-...
👤 Annalisa Ruggeri, Co-Chair of #CART26
#CellTherapy #HCT #CARTcell
Hello from Tandem in Salt Lake City 👋
The BMT InfoNet team is meeting with transplant and CAR T healthcare professionals and sharing resources. Stop by!
Plus… today’s award for cutest booth visitor definitely goes to this little one. 🐶
#TandemMeetings #TransplantCommunity #CARTcell #PatientSupport
Just one week to go until #CART26 kicks off in Palma de Mallorca, Spain, and online!🇪🇸 💻
Hear from the meeting chair, Annalisa Ruggeri, who encourages you to register for this hybrid meeting:
🎥 buff.ly/poXdp9x
Register here:
➡️ buff.ly/LMXQ0qU..
#CARTCell #ImmunoOnc #HemOnc @theebmt.bsky.social
#Tandem26 has begun! Come see us at booth # 511.
🧫 Meet the Scientists of Eurofins Viracor
🎙 Be a guest on Transplant Radio™
🎨 Win a painting from world renowned artist, "Scribe" Donald Ross
#Tandem2026 #gvhd #cartcell
The CAR T field is shifting to in vivo platforms that aim to make powerful cell therapies simpler, cheaper, and more accessible. Insights from Vyriad's Luke Russell. #CARTcell #immunotherapy #invivo #biotech #Vyriad #oncology #celltherpay
The CAR T field is shifting to in vivo platforms that aim to make powerful cell therapies simpler, cheaper, and more accessible. Insights from Vyriad's Luke Russell. #CARTcell #immunotherapy #invivo #biotech #Vyriad #oncology #celltherpay
The February issue is out now! Highlights include articles on the growing use of #AI in clinical #research, use of #DOACs in pediatric #thrombosis, public sector approaches to address unequal #CARTcell access, and more. Check out the full lineup here: https://ow.ly/LS7I50Y8gyW
#HemeSky #MedSky
Today, on #WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2026 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! https://www.broermann-award.org/nomination/ #cancer #cancercure #cancertreatment #cartcell #immunotherapy
Today, on #WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2026 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! https://www.broermann-award.org/nomination/ #cancer #cancercure #cancertreatment #cartcell #immunotherapy
Today, on #WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2026 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! https://www.broermann-award.org/nomination/ #cancer #cancercure #cancertreatment #cartcell #immunotherapy
Today, on #WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2026 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! https://www.broermann-award.org/nomination/ #cancer #cancercure #cancertreatment #cartcell #immunotherapy
Today, on #WorldCancerDay, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June & Prof. Michel Sadelain, whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment.
#cancer #cancercure #cancertreatment #cartcell #immunotherapy
📣 One of Europe’s leading forums dedicated to CAR T-cell therapies is taking place next week. #CART26
💻 Can’t make it in person? Most sessions will be livestreamed, allowing you to stay connected wherever you are. 🌎
Save your spot: ebmt.org/events/ebmt-...
#CARTcell #HCT #celltherapy #genetherapy
For solid #tumors, the real barrier is often the #tumor microenvironment, not the #cancer cell itself. Reprogramming tumor-associated macrophages could be the breakthrough that finally extends #CARTcell therapy beyond blood cancers.
www.linkedin.com/posts/drmelv...
👏 In less than a month, our scientific community gathers in 📍 Palma de Mallorca to discuss the evolving landscape of CAR T therapies.
📢 There's still time to register and join either in person or virtually. Learn more ➡️ ebmt.org/events/ebmt-...
#CARTcell #celltherapy #scientificmeeting
Want to find out about the latest advances in #CARTCell therapy?🩸💉
Register for the EBMT-EHA 8th European CAR T-cell Meeting taking place next month, and stay tuned for our exclusive coverage of this fantastic event!🎥
Click here to register:
👉 buff.ly/kVxJ8jg.. 👈
#CART26 @theebmt.bsky.social
➡️Then, read the related commentary, Beyond Expansion: Tumor Debulking as Key to Improving CAR T-Cell Potential in #Lymphoma buff.ly/9qvDl6d #cartcell
Check out this new Research Brief in Blood Cancer Discovery: A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell #Lymphoma buff.ly/2qj56s0 #cartcell
ExPeCT™ anti‑CD19 (FMC63) CAR T qPCR gives clinicians the visibility they’ve been missing.
Talk to us in person at Booth# 511.
#HemOnc #CARTcell #ExPeCTViracor
We are thrilled to be the official media partner for the annual EBMT-EHA European CAR T-cell Meeting, taking place in Palma de Mallorca, Spain, from 12–14 February! 🇪🇸
Want to join us there or attend virtually?
Register here:
👉 buff.ly/HFpKa82..
#CARTCell #CART26 @theebmt.bsky.social
#CARTcell therapy has revolutionized the treatment of various hematologic malignancies. But could it also have a role in treating refractory autoimmune diseases? What do findings from case reports and early clinical trials indicate?
👉 buff.ly/1bXYlvr
#RheumSky
What advancements in #CARTcell therapy have we seen in #rheumatology in 2025?
Sarah Onuora, Chief Editor of @natrevrheum.nature.com, discusses this and the other hot topics this year in our latest podcast.
Listen now 👉 buff.ly/t5vUVzy
#RheumSky #MedSky
With 1st & senior authors of our systematic review and meta-analysis of nonrelapse mortality after #CARTcell published in @natmed.nature.com Kai Rejeski & David Cordas Dos Santos #ash25
share.google/uJORJp09BmSP...
#ASH25 Anito-cel, a new anti-BMCA #CARTcell therapy with a unique D-domain binder that may lead to more therapeutic efficacy, was found to produce strong rates of response in patients with R/R #MultipleMyeloma #MMsm, with an ORR of 97% and CR/sCR of 68%: https://ow.ly/P9Gj50XCNnl
#HemeSky #OncSky
#CARTCell based hyperlocalized targeting of #InflammatoryPathways involved in development of #AtheroscleroticPlaque doi.org/10.1161/CIRC... @IAmDrDex @PoseyLab #CellTherapy #ImmunoTherapy #Atherosclerosis #TranslationalScience
A longer time from T-cell collection to infusion of #CARTcell therapy was associated with worse outcomes, particularly with regard to PFS and OS, in patients with R/R #DLBCL, according to findings from a small retrospective trial conducted in Japan: https://ow.ly/SwTh50XAlhw
